Resolution of Tissue Signatures of Therapy Response in Patients with Recurrent GBM Treated with Neoadjuvant Anti-PD1
Science in Seattle,
The response of patients with recurrent glioblastoma multiforme to neoadjuvant immune checkpoint blockade has been challenging…